Argenica Therapeutics Limited (AGN.AX)
AUD 0.76
(4.83%)
AUD 0.76
(4.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.67 Million AUD | 14.4% |
| 2023 | -6.62 Million AUD | -61.98% |
| 2022 | -4.08 Million AUD | -297.3% |
| 2021 | -1.02 Million AUD | -168.32% |
| 2020 | -383.65 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -2.1 Million AUD | 44.8% |
| 2024 Q4 | -2.1 Million AUD | 0.0% |
| 2024 FY | -8.26 Million AUD | -24.82% |
| 2024 Q2 | -3.81 Million AUD | -422.02% |
| 2024 Q1 | -730.51 Thousand AUD | 80.12% |
| 2023 Q2 | -2.94 Million AUD | -275.3% |
| 2023 FY | -6.62 Million AUD | -61.98% |
| 2023 Q4 | -3.67 Million AUD | -122.52% |
| 2023 Q3 | -1.65 Million AUD | 44.02% |
| 2023 Q1 | -786.03 Thousand AUD | 66.49% |
| 2022 FY | -4.08 Million AUD | -297.3% |
| 2022 Q3 | -1.17 Million AUD | 41.52% |
| 2022 Q2 | -2 Million AUD | -129.67% |
| 2022 Q1 | -873.33 Thousand AUD | 20.23% |
| 2022 Q4 | -2.34 Million AUD | -100.0% |
| 2021 FY | -1.02 Million AUD | -168.32% |
| 2021 Q2 | -230.84 Thousand AUD | -807.71% |
| 2021 Q4 | -1.09 Million AUD | -100.0% |
| 2021 Q1 | 32.61 Thousand AUD | 108.51% |
| 2021 Q3 | -547.43 Thousand AUD | -137.15% |
| 2020 Q2 | -200.00 AUD | 0.0% |
| 2020 FY | -383.65 Thousand AUD | 0.0% |
| 2020 Q4 | -383.45 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | -7.785% |
| Acrux Limited | -9.83 Million AUD | 42.331% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -28.164% |
| Biome Australia Limited | -1.91 Million AUD | -196.419% |
| BTC Health Limited | 1.05 Million AUD | 637.409% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 53.929% |
| CSL Limited | 5.64 Billion AUD | 100.1% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 87.341% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 111.539% |
| Noxopharm Limited | -7.53 Million AUD | 24.735% |
| PharmAust Limited | -6.65 Million AUD | 14.829% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 21.577% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 21.084% |
| PYC Therapeutics Limited | -38.85 Million AUD | 85.405% |
| Race Oncology Limited | -13.38 Million AUD | 57.616% |
| Starpharma Holdings Limited | -15.15 Million AUD | 62.589% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 158.366% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 61.42% |
| Memphasys Limited | -2.7 Million AUD | -109.734% |
| Nyrada Inc. | -4.56 Million AUD | -24.36% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -288.671% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -85.184% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 4.497% |
| Patrys Limited | -3.53 Million AUD | -60.242% |
| Dimerix Limited | -25.05 Million AUD | 77.369% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 102.51% |
| Orthocell Limited | -11.68 Million AUD | 51.45% |
| Imugene Limited | -140.93 Million AUD | 95.976% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 35.612% |
| Immutep Limited | -44.93 Million AUD | 87.38% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 21.157% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 71.068% |
| Nanollose Limited | -1.24 Million AUD | -353.76% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -165.801% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -175.762% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -97.343% |
| Biotron Limited | -5.15 Million AUD | -10.095% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 87.987% |
| Tissue Repair Ltd | -4.87 Million AUD | -16.31% |
| AnteoTech Limited | -11.72 Million AUD | 51.638% |
| Hexima Limited | -1 Million AUD | -462.201% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 91.29% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 74.282% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -23.577% |
| Actinogen Medical Limited | -12.83 Million AUD | 55.828% |
| Immuron Limited | -5.8 Million AUD | 2.239% |